Search

everythinglearnresearchcommunity

for

Search:↓

Cyproterone acetate may cause liver cancer at high doses, but is considered safe at recommended doses for approved uses.

Many women experience sexual dysfunction, but few seek help, and better treatment and medical training are needed.

Oxidative stress affects hair loss in men with androgenetic alopecia.

ADSC-CM treatment improved hair density and thickness in women with hair loss, safely and effectively.

Aromatase gene variation may increase female hair loss risk.

Neurosteroids show promise for treating epilepsy and more research is needed.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

Seborrhea in Parkinson's disease may be linked to hormones, not autonomic impairment.

Men who experienced baldness at age 20 may have double the risk of getting prostate cancer.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

Diagnosing PCOS in teenagers is hard because its symptoms often look like normal puberty, and there's a need for better diagnosis methods and agreement on criteria.

Finasteride can cause sexual problems and depression in young men.

New pregnane derivatives are effective at inhibiting an enzyme linked to hair loss and reducing oil gland activity.

Mice lacking steroid 5α-reductase 2 show less aggression and better impulse control.

Changing the C-ring structure in certain compounds can make them better at blocking a specific human enzyme.

Androgens increase EPO production, finasteride doesn't significantly impact it.

The peptide GPIGS helps hair cells grow and speeds up hair regrowth in mice.

Removing p16INK4a from skin cells can lead to faster and more clumped growth, which might help with hair growth.

Inositol was more effective than metformin in improving menstrual cycles and pregnancy rates in PCOS patients.

Some skin conditions are associated with other serious diseases, and office microscopy may miss many fungal infections.

Anti-IL-1 treatments might help with certain types of hair loss in people with high inflammation.

Blocking IL-1 could help treat some hair loss conditions; alopecia affects liver detox systems; spironolactone is better than finasteride for female hair growth; focusing on the catagen hair phase could lead to new alopecia treatments.

Alopecia patients have a less active liver monoxygenase system, which can be treated with photochemotherapy and system inducers.

Anticancer drugs are increasingly found in surface waters, and their long-term environmental effects are not well understood, requiring better testing methods.

Mutations in the SRD5A3 gene cause a new type of glycosylation disorder by blocking the production of a molecule necessary for protein glycosylation.

The conclusion is that proper signaling is crucial for hair growth and development, and errors can lead to cancer or hair loss.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

Finasteride treats enlarged prostate and hair loss, but may cause side effects in some patients.

Obesity worsens PCOS symptoms, and PCOS may lead to more weight gain; managing both requires a holistic approach that includes mental health.